174 related articles for article (PubMed ID: 15282093)
1. Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.
Zufía L; Aldaz A; Giráldez J
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):51-8. PubMed ID: 15282093
[TBL] [Abstract][Full Text] [Related]
2. A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
Vainchtein LD; Rosing H; Schellens JH; Beijnen JH
Biomed Chromatogr; 2010 Apr; 24(4):374-86. PubMed ID: 19650151
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry.
Deenen MJ; Rosing H; Hillebrand MJ; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():30-40. PubMed ID: 23270936
[TBL] [Abstract][Full Text] [Related]
4. Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection: validation for application in clinical pharmacokinetic studies.
Zufía L; Aldaz A; Castellanos C; Giráldez J
Ther Drug Monit; 2003 Apr; 25(2):221-8. PubMed ID: 12657918
[TBL] [Abstract][Full Text] [Related]
5. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
[TBL] [Abstract][Full Text] [Related]
7. Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma.
Piórkowska E; Kaza M; Fitatiuk J; Szlaska I; Pawiński T; Rudzki PJ
Pharmazie; 2014 Jul; 69(7):500-5. PubMed ID: 25073394
[TBL] [Abstract][Full Text] [Related]
8. Rapid and simultaneous determination of capecitabine and its metabolites in mouse plasma, mouse serum, and in rabbit bile by high-performance liquid chromatography.
Dhananjeyan MR; Liu J; Bykowski C; Trendel JA; Sarver JG; Ando H; Erhardt PW
J Chromatogr A; 2007 Jan; 1138(1-2):101-8. PubMed ID: 17070825
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
10. Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients.
Poole C; Gardiner J; Twelves C; Johnston P; Harper P; Cassidy J; Monkhouse J; Banken L; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 2002 Mar; 49(3):225-34. PubMed ID: 11935215
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma.
Xu Y; Grem JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):273-85. PubMed ID: 12450548
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
Reigner B; Verweij J; Dirix L; Cassidy J; Twelves C; Allman D; Weidekamm E; Roos B; Banken L; Utoh M; Osterwalder B
Clin Cancer Res; 1998 Apr; 4(4):941-8. PubMed ID: 9563888
[TBL] [Abstract][Full Text] [Related]
13. A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.
Farkouh A; Ettlinger D; Schueller J; Georgopoulos A; Scheithauer W; Czejka M
Anticancer Res; 2010 Dec; 30(12):5207-11. PubMed ID: 21187514
[TBL] [Abstract][Full Text] [Related]
14. Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
Knikman JE; de Vries N; Rosing H; Cats A; Guchelaar HJ; Beijnen JH
Pharmazie; 2023 Aug; 78(8):107-112. PubMed ID: 37592424
[TBL] [Abstract][Full Text] [Related]
15. Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma.
Chu D; Gu J; Liu W; Paul Fawcett J; Dong Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):377-82. PubMed ID: 14522043
[TBL] [Abstract][Full Text] [Related]
16. Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients.
Li KM; Rivory LP; Clarke SJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):121-30. PubMed ID: 15866500
[TBL] [Abstract][Full Text] [Related]
17. Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.
Twelves C; Glynne-Jones R; Cassidy J; Schüller J; Goggin T; Roos B; Banken L; Utoh M; Weidekamm E; Reigner B
Clin Cancer Res; 1999 Jul; 5(7):1696-702. PubMed ID: 10430071
[TBL] [Abstract][Full Text] [Related]
18. The rational development of capecitabine from the laboratory to the clinic.
Pentheroudakis G; Twelves C
Anticancer Res; 2002; 22(6B):3589-96. PubMed ID: 12552961
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
Saeki T; Takashima S
Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
